Reuters -- Clinical testing company Covance Inc (CVD.N) lowered its full-year outlook, partly due to delays in the start of late-stage studies, and said it would cut 200 jobs in the second quarter as it closes two smaller sites.
Reuters -- Clinical testing company Covance Inc (CVD.N) lowered its full-year outlook, partly due to delays in the start of late-stage studies, and said it would cut 200 jobs in the second quarter as it closes two smaller sites.
